Open Medicine Foundation®
Leading research. Delivering hope.
ME/CFS and related chronic complex diseases

News Blog

Medscape: New Findings Elucidate Potentially Treatable aspects of ME/CFS

By Miriam Tucker Bethesda, Maryland – New evidence of cardiopulmonary and nervous system abnormalities in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) yields clues to the etiology of their exercise intolerance and points to potential treatments. The findings were presented during the 2-day Accelerating Research on ME/CFS Meeting sponsored by the National Institutes of Health (NIH) and...

Read More

NIH Accelerating Research on ME/CFS Recordings

The videocast recordings from the NIH Conference “Accelerating Research on ME/CFS” held on April 4 & 5, 2019 are available below. Day 1: Day 2:

Read More

OMF Research Update from Ronald W. Davis, PhD

OMF Phoenix Rising Correspondent, Ben Howell, interviewed Dr. Ron Davis with inquiring questions from a patient’s perspective. Watch their in-depth conversation on OMF’s Youtube channel here.

Read More

IIMEC14 Registration Opens and Full Agenda Announced

The 14th International Invest in ME Conference (IiMEC14) in London on May 31, 2019 is set. The agenda has been posted. Four members of OMF’s Scientific Advisory Board will be presenting: Ronald W. Davis, PhD, Øystein Fluge, MD, PhD, Maureen Hanson, PhD, and Ronald G. Tompkins, MD, ScD.  Registration is now open. Members of our team will also be participating...

Read More

Second Annual ME/CFS Expert Clinician Summit

Linda Tannenbaum, OMF Founder and CEO/President, will join the leading U.S. ME/CFS experts as they convene for the Second Annual ME/CFS Clinician Summit on March 15-16 in Salt Lake City, Utah. This event is significant because it marks progress and forward momentum for this dedicated group as they tackle the ambitious goal of mainstreaming ME/CFS in...

Read More

Hope & Heart Unite for ME/CFS Poetry & Art Slam Winner – Even Though

When we announced the Hope & Heart Unite for ME/CFS Poetry & Art Slam project together with Lev Leytzan, we said, “Your words and art have power.” The heart and hope shared in your words and images truly left us speechless. We thank each and every person who submitted a heartfelt entry. You have truly touched...

Read More

Follow Members of OMF’s Scientific Advisory Board and Other Esteemed Scientists at Emerge Australia’s International Research Symposium

We want to thank again Emerge Australia for hosting the International Research Symposium on ME/CFS. Along with leading international researchers, OMF-funded researchers including Scientific Advisory Board Director Ronald W. Davis, PhD, Jonas Bergquist, MD, PhD, Wenzhong Xiao, PhD, Robert Phair, PhD, and Christopher Armstrong, PhD, will be presenting.   Emerge has just announced that the...

Read More

Linda Tannenbaum Shares Hope on The ME Show

Gary Burgess, UK reporter, has interviewed Linda Tannenbaum, OMF Founder & CEO/President, for his podcast, The ME Show. This new podcast is supported by the ME Association UK. In this podcast Linda reviews the history of OMF, our research focus, and shares a message of HOPE for all. Listen to The ME Show episode featuring Linda...

Read More

Together Our Community Soared in 2018

On behalf of our OMF Team, including our Board of Directors, Scientific Advisory Board, and patients around the world, thank you for your impactful support helping to make 2018 a banner year in ME/CFS research. With more than $9 million raised in 2018, we are able to accelerate our efforts to engage more researchers and...

Read More

OMF-funded Red Blood Cell Deformability Research Study Published

As promised, below is the link to the complete version of the Red Blood Cell (RBC) Deformability research paper, which has now been formally published, open source, in Clinical Hemorheology and Microcirculation. The authors are Mohsen Nemat-Gorgani, PhD, of Stanford University, and Anand Ramasubramanian, PhD, of San Jose State University, in collaboration with Ron Davis, PhD, and their teams.  This important...

Read More

Stay Informed

Be the first to hear our research news.

Subscribe Now.

No thanks